Indefinite Delivery Contract 36E79725D0037
Award Date
9/24/25
Last Date to Order
9/23/26
Federal Agency
National Acquisition Center
Awardee
Xlcare Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods. The contract is for the supply of losartan...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The contract has a ceiling value of $18,554,214.00 and a period of performance from May 24, 2021 to May 23, 2022, with four one-year option periods. The contract is for the supply of levetiracetam tablets to the VA, Department of Defense...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business certified as an economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $28,973,375.80 and a base period of one year from June 26, 2022 to June 25, 2023, with four one-year option periods. The contract is for the supply of delayed-release pantoprazole...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to provide 12 line items of aripiprazole tablets. The $9,697,748.40 IDC was awarded on February 1, 2021 for a base year and four one-year option periods, with an ultimate completion date of January 31, 2026. The contract will supply aripiprazole tablets in various package sizes to the VA,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned small disadvantaged business, to provide Topiramate tablets over a 1-year base period and four 1-year option periods, for a total potential contract value of $14,134,788.05. The contract will support the VA, Department of Defense, Bureau of Prisons, and Indian Health Service by providing an uninterrupted supply of Topiramate tablets in...
The National Acquisition Center, a civilian agency of the U.S. federal government, has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $761,850 contract is for the supply of lacosamide injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period with four one-year option periods. This IDC was competitively awarded without any...
The indefinite delivery contract (IDC) 36E79721D0051 was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is also certified as an economically disadvantaged woman-owned small business. The contract, which has a ceiling value of $1,423,620.00, is for the supply of dutasteride capsules to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract was...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Avkare LLC, a pharmaceutical and medical supply company. The contract has a ceiling value of $21,739,614.15 and a period of performance from June 21, 2021 to June 20, 2026, with an initial one-year base period and four one-year option periods. The contract is for the delivery of Carbidopa/Levodopa tablets in various sizes to support the healthcare...